Breast Cancer Detection Patterns in Year 2 of the COVID ‐19 Pandemic Highlight Gains and Gaps in Breast Cancer Surveillance
Cancer Medicine · 2025
DOI: 10.1002/cam4.71275 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2025. Verfasst von Susan J Doh und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Surgical Oncology, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA. Hauptthemen laut MEDLINE: Breast Neoplasms, COVID-19, Early Detection of Cancer. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
The COVID‐19 pandemic severely hindered breast cancer (BC) diagnoses. We investigated the impact of COVID‐19 on BC diagnoses in the US.
Methods
We retrospectively reviewed the 2024 release of the Surveillance, Epidemiology, and End Results database (SEER: 2000–2021) for invasive BC incidences per 100,000 in adult women. Using the SEER Joinpoint software, we modeled BC incidence trends through 2019 and extrapolated expected incidences in 2020–2021. We compared expected and observed incidences and calculated percent differences (PD) and the national deficit in diagnoses.
Results
Observed BC incidence in 2020 was 122.03, while expected incidence was 132.14, yielding a PD of −7.6% [−8.9%, −6.4%]. In 2021, observed BC incidence exceeded projections (3.5% [2.1%, 4.8%]). These translated to a cumulative deficit of 7190 cases [−11,886, −2494] during 2020–2021. Localized and regional BC detection decreased in 2020 and was within (1.4% [−0.9%, 3.7%]) or exceeded (4.1% [4.2%, 4.4%]) projections, respectively, in 2021. Distant disease detection was within projections in 2020 and exceeded projections in 2021 (3.9% [0.6%, 7.2%]). Across most demographic subgroups, detection was low in 2020. In 2021, cases exceeded projections in White women and metropolitan and high education/income counties, were within projections in racial/ethnic minorities and rural and low education/income counties, and were below projections in 85+ year olds and 10%–19.99% foreign‐born counties.
Conclusions
BC detection recovered in 2021 compared to the start of the pandemic, but notable disparities persisted. Careful surveillance and study are needed to prevent further gaps in BC detection years after the pandemic.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Surgical Oncology, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.
- School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA.
- Department of Population and Quantitative Health Sciences, School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA.
- Case Comprehensive Cancer Center, School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA.
- Department of Internal Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.
ORCID-Profile: Susan J Doh
Zitieren
APA
Doh, S. J., Lal, T., Chakraborty, N., Kim, U., & Hoehn, R. S. (2025). Breast Cancer Detection Patterns in Year 2 of the COVID ‐19 Pandemic Highlight Gains and Gaps in Breast Cancer Surveillance. Cancer Medicine. https://doi.org/10.1002/cam4.71275
Vancouver
Doh SJ, Lal T, Chakraborty N, Kim U, Hoehn RS. Breast Cancer Detection Patterns in Year 2 of the COVID ‐19 Pandemic Highlight Gains and Gaps in Breast Cancer Surveillance. Cancer Medicine. 2025. doi:10.1002/cam4.71275
BibTeX
@article{Doh2025,
author = {Doh, Susan J and Lal, Trisha and Chakraborty, Natalie and Kim, Uriel and Hoehn, Richard S},
title = {Breast Cancer Detection Patterns in Year 2 of the COVID ‐19 Pandemic Highlight Gains and Gaps in Breast Cancer Surveillance},
journal = {Cancer Medicine},
year = {2025},
doi = {10.1002/cam4.71275}
}
EUVIMED